09: What the HEK is new in immunotherapy? (2024 recap)

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/dd/35/58/dd355821-5776-9ac7-92eb-5071708ca0bc/mza_3299975214303003788.jpg/600x600bb.jpg

What the HEK is Immunotherapy?

WTHisImmunotherapy

16 episodes

5 days ago

What the HEK is immunotherapy? With this podcast we are trying to answer that question! Through interviews with professors, students, patients, and other experts in the field we hope to introduce different types of immunotherapy and the research that is ongoing, specifically within the Canadian field. Join us as we try to make immunotherapy more digestible! Creators & Producers: Gillian Savage, Grace Bernard, and Dr. Pauline Loos Podcast Logo is designed by Mia Portelance Music is by Lara Antebi (https://laraantebi.bandcamp.com/)

Life Sciences

Science

RSS

All content for What the HEK is Immunotherapy? is the property of WTHisImmunotherapy and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40710401/40710401-1709789502523-2c350c9428baa.jpg

09: What the HEK is new in immunotherapy? (2024 recap)

What the HEK is Immunotherapy?

25 minutes 36 seconds

10 months ago

09: What the HEK is new in immunotherapy? (2024 recap)

To end off the year Grace and Gillian dive into some of the scientific findings and news they found most interesting in the immunotherapy field for 2024! We hope this gets you excited about the progress of immunotherapy and the many breakthroughs to come!

For more information on the immunotherapies discussed here check out the links below:

Lifileucel, the first FDA-approved TIL product: https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-amtagvi-til-therapy-melanoma

CAR T cell therapy for autoimmune disease: https://www.nejm.org/doi/full/10.1056/NEJMoa2308917 and https://www.science.org/content/article/breakthrough-cancer-immunotherapy-now-taking-aim-autoimmune-disease

7th approved CAR T cell product (AUCATZYL): https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-obecabtagene-autoleucel-adults-relapsed-or-refractory-b-cell-precursor-acute

First FDA-approved CAR T cell product for CLL: https://www.lls.org/news/fda-approves-first-car-t-cell-therapy-chronic-lymphocytic-leukemia#:~:text=Rye%20Brook%2C%20N.Y.%2C%20March%2019,not%20responded%20to%20previous%20treatments.

Breast cancer vaccine: https://ascopost.com/news/november-2024/breast-cancer-vaccine-could-be-preventive-well-tolerated-in-high-risk-patients/

FDA approval of first TCR therapy for synovial sarcoma (Afami-cel): https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-tecelra-synovial-sarcoma-mage-a4

Personalized engineered TCR TIL therapy phase II study: https://www.cancer.gov/news-events/press-releases/2024/personalized-immunotherapy-shrinks-solid-tumors

Long term checkpoint blockade therapy followup: https://news.weill.cornell.edu/news/2024/09/long-term-metastatic-melanoma-survival-dramatically-improves-on-immunotherapy

Interested in learning more about immunotherapy? Check out our other episodes and give us a follow on instagram @wthisimmunotherapy and twitter @WTHisImmunoT! And check out our website ⁠wthisimmunotherapy.com⁠. Or feel free to reach out to us at ⁠wthisimmunotherapy@gmail.com⁠ if you have any questions or any ideas for episodes!

Creators & Producers: Gillian Savage, Grace Bernard, and Dr. Pauline Loos

Podcast Logo is designed by Mia Portelance

Music is by Lara Antebi (⁠https://laraantebi.bandcamp.com/⁠)